Phage Cocktail Therapy: Multiple Ways to Suppress Pathogenicity.
Sign Up to like & getrecommendations! Published in 2020 at "Trends in plant science"
DOI: 10.1016/j.tplants.2020.01.013
Abstract: Phage cocktails have emerged as precision tools for controlling plant bacterial diseases. Wang et al. now report that phage cocktails decreased the occurrence of tomato bacterial wilt disease efficiently by infecting and destroying bacterial pathogens,… read more here.
Keywords: ways suppress; therapy multiple; phage; phage cocktail ... See more keywords
Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT
Sign Up to like & getrecommendations! Published in 2019 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-019-0525-1
Abstract: Ana Pilar Gonzalez-Rodriguez ● Lucia Lopez-Corral ● David Fernando Moreno Fajardo ● Ana Julia Gonzalez-Huerta ● Pilar Palomo ● Arantxa Bermudez ● Teresa Zudaire Ripa ● Patricia Santos-Diaz ● Soledad Gonzalez-Muñiz ● Joud Zanabilli 1… read more here.
Keywords: therapy multiple; daratumumab safe; effective rescue; gonzalez ... See more keywords
Continuous Renal Replacement Therapy for Multiple Organ Injury Induced by Raw Fish Gallbladder Poisoning.
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000000491
Abstract: gested urinary tract infection, and she was adequately treated. But all cultures (blood, urine, and stool) came negative throughout the hospitalization. Imaging showed extensive mandibular erosion suggestive of surgical debridement versus chronic osteomyelitis. Autoinflammatory, abscess,… read more here.
Keywords: replacement therapy; therapy multiple; continuous renal; organ injury ... See more keywords
Maintenance therapy in multiple myeloma: Two is not always better than one
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18614
Abstract: In multiple myeloma (MM) long‐term therapy aims to control disease and delay progression for as long as possible. In this issue Jenner et al. failed to demonstrate a benefit of maintenance with lenalidomide plus vorinostat… read more here.
Keywords: maintenance therapy; multiple myeloma; myeloma; therapy multiple ... See more keywords
Initial High-Efficacy Disease-Modifying Therapy in Multiple Sclerosis
Sign Up to like & getrecommendations! Published in 2022 at "Neurology"
DOI: 10.1212/wnl.0000000000201391
Abstract: In the Research Article “Initial High-Efficacy Disease-Modifying Therapy in Multiple Sclerosis: A Nationwide Cohort Study” by Buron et al.,1 2 authors were mistakenly omitted from the final manuscript. Dr. Danny Bech, MD, should appear as… read more here.
Keywords: therapy multiple; high efficacy; modifying therapy; disease modifying ... See more keywords
Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers
Sign Up to like & getrecommendations! Published in 2022 at "Pathology and Oncology Research"
DOI: 10.3389/pore.2022.1610276
Abstract: Despite the introduction of novel agents, multiple myeloma remains incurable for most patients, necessitating further therapeutic options. Venetoclax, a selective BCL-2 inhibitor, had shown promising results in patients with translocation t(11;14), but questions remain open… read more here.
Keywords: venetoclax therapy; myeloma; targeted venetoclax; multiple myeloma ... See more keywords
Biology and therapy of multiple myeloma
Sign Up to like & getrecommendations! Published in 2019 at "Medical Journal of Australia"
DOI: 10.5694/mja2.50129
Abstract: Genetic sequencing of the myeloma genome has not revealed a specific disease‐determining genetic alteration. Multiple disease subclones exist at diagnosis and vary in clinical importance with time and drug sensitivity. New diagnostic criteria have identified… read more here.
Keywords: therapy multiple; biology therapy; multiple myeloma; biology ... See more keywords